Yellow Fever Vaccine: Introduction
- Yellow fever is a serious, potentially deadly flu-like disease spread by Aedes aegypti mosquitoes, which also transmit dengue and Zika viruses. It’s characterized by a high fever and jaundice. Jaundice is yellowing of the skin and eyes, which is why this disease is called yellow fever.
- Yellow fever is typically transmitted from human to human through the bite of an infected Aedes aegypti mosquito. Symptoms of yellow fever include high fever, headache, fatigue, muscle pain, diarrhea, anemia, skin rashes, and vomiting. Yellow fever has high mortality rate and can cause various neurological complications. Yellow fever causes CNS manifestations, which includes any degree of impaired consciousness, abnormal neurological signs, delirium, and focal and generalized convulsions. Causes of neurological manifestations in yellow fever are due to high-grade fever. Numerous tests are available to confirm the diagnosis including detecting antibodies to the virus or its RNA. Management of yellow fever is a challenge that needs to be addressed.
Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=81992
Key Drivers of Global Yellow Fever Vaccine Market
- The global yellow fever vaccine market is anticipated to expand rapidly in the near few years. Rising prevalence of dengue, increasing novel drug treatment, convenience of direct purchase, affordability of vaccine, high adoption and acceptance in developing markets, and innovations and developments in vaccine are key factors driving the market.
- The market is also witnessing certain restraints such as intense competition among existing players to develop new vaccine, high possibilities of side-effects of vaccine, complications and severity involved in taking wrong medications due to misdiagnosis or incorrect self-diagnosis, and lack of awareness among the rural population in developing and underdeveloped economies
Request for Analysis of COVID19 Impact on Yellow Fever Vaccine Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=81992
Hospitals to be Highly Attractive Segment
- In terms of end-user, the global yellow fever vaccine market can be classified into hospitals, diagnostic centers, point of care centers, and others
- The hospitals segment is expected to account for a major share of the global yellow fever vaccine market by 2031, due to easy access for outpatient department (OPD) patients to buy medicines
Pre book Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=81992<ype=S
North America to Offer Significant Opportunities in Yellow Fever Vaccine Market
- In terms of region, the global yellow fever vaccine market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is the leading market for yellow fever vaccine, in terms of revenue, followed by Europe. The U.S. accounted for a prominent share of the market in the region. Asia Pacific and Latin America are emerging markets, which are expected to witness robust expansion during the forecast period.
- Expansion of the market in these regions is attributed to a rise in incidence of yellow fever, expansion of the healthcare industry, and increase in government investment to develop healthcare infrastructure. The yellow fever vaccine market in countries such as China, India, and Brazil is projected to expand at high growth rate during the forecast period due to increased awareness about yellow fever disease and its treatment among the population in these countries.
Ask for Discount :
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=81992
Key Players Operating in Global Yellow Fever Vaccine Market
The global yellow fever vaccine market is consolidated, with the presence of very less number of international and local players. Key players operating in the global yellow fever vaccine market are:
- Sanofi Pasteur SA
- Bio-Manguinhos
- Institut Pasteur de Dakar
- FSUE Chumakov
- iBio Inc.
- Panacea Biotec
- Biological E. Limited
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Takeda Pharmaceutical Company Ltd.
Browse more Market Reports:
Intra-Abdominal Pressure Measurement Devices Market:
Cancer Supportive Care Products Market:
http://www.transparencymarketresearch.com/cancer-supportive-care-products-market.html
Infection Prevention Devices Market:
https://www.transparencymarketresearch.com/infection-prevention-devices-market.html
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
